TILMIX INJECTION FOR CATTLE

Riik: Austraalia

keel: inglise

Allikas: APVMA (Australian Pesticides and Veterinary Medicines Authority)

Toimeaine:

TILMICOSIN PHOSPHATE

Saadav alates:

JUROX PTY LIMITED

Ravimvorm:

PARENTERAL LIQUID/SOLUTION/SUSPENSION

Koostis:

TILMICOSIN PHOSPHATE ANTIBIOTIC Active 300.0 mg/ml

Ühikuid pakis:

100 mL; 250 mL

Klass:

VM - Veterinary Medicine

Terapeutiline ala:

ANTIBIOTIC & RELATED

Toote kokkuvõte:

Poison schedule: 4; Withholding period: MEAT - DO NOT USE less than 28 days befo re slaughter for human consumption. MIL K - DO NOT USE in lactating cows where m ilk or milk products may be used for hum an consumption. Any variation by the pr escribing veterinarian to the approved d ose, frequency, duration, route, disease , or target species may require extendin g the approved withholding period. EXPO RT SLAUGHTER INTERVAL (ESI): DO NOT USE less than 42 days before slaughter for e xport. Before using this product, confir m the current ESI from the registration holder on 1800 023 312 or the APVMA webs ite (www. apvma.gov.au/residues); Host/pest details: CATTLE: [BOVINE RESPIRATORY DISEASE, MANNHEIMIA HAEMOLYTICA, PASTEURELLA MULTOCIDA]

Volitamisolek:

Registered

Loa andmise kuupäev:

2023-07-01

Infovoldik

Product Name:
APVMA Approval No:
TILMIX INJECTION FOR CATTLE
87565/118677
Label Name:
TILMIX INJECTION FOR CATTLE
Signal Headings:
PRESCRIPTION ANIMAL REMEDY
KEEP OUT OF REACH OF CHILDREN
FOR ANIMAL TREATMENT ONLY
Constituent
Statements:
ACTIVE CONSTITUENT
300 mg/mL TILMICOSIN (as tilmicosin phosphate)
Claims:
For use in lot-fed cattle for the treatment of Bovine Respiratory
Disease (BRD) associated
with Mannheimia (Pasteurella) haemolytica, Pasteurella multocida and
other organisms
susceptible to tilmicosin.
Net Contents:
100 mL
250 mL
Directions for Use:
Restraints:
DO NOT USE in lactating cows where milk or milk products may be used
for human
consumption.
Contraindications:
This product must not be administered intravenously or
intramuscularly.
Inject subcutaneously only in cattle. Intravenous injection in cattle
has been fatal.
Pneumatic or hydraulically operated syringes should not be used with
this product.
This product is contraindicated for use in pigs, goats and non-human
primates. Injection
has been shown to be fatal in pigs, non-human primates, goats, sheep
(intravenous
injection) and lambs less than 15 kg bodyweight. Tilmicosin may be
fatal in horses.
Precautions:
The safety of tilmicosin has not been established in pregnant cattle. RLP APPROVED
Side Effects:
Dosage and
Administration:
For subcutaneous injection only in cattle
Use the contents of the vial within 90 days of initial broaching and
discard any unused
portion.
Administer a single subcutaneous injection of 10 mg tilmicosin / kg
bodyweight (1 mL per
30 kg), using a standard disposable syringe or multi-filling syringe.
With a single hand
on the syringe, insert the needle subcutaneously, at a top-down angle,
whilst avoiding
penetration of underlying muscle. Do not inject more than 25 mL per
injection site.
Subcutaneous injection must be made high into the neck. If no
improvement is noted within
48 hours the diagnosis should be re-evaluated.
Single dose only.
NOTE: Swelling at the subcutaneous site of injection may be observed
but is transient